BIOVACSAFE

BioVacSafe is a public private consortium of 19 partners involving three of Europe's leading vaccine producing companies, experts from major academic institutions, small and medium-sized enterprises (SMEs) and non-governmental organization (NGO) actors... BioVacSafe aims at establishing tools, methods and guidelines for the evaluation of vaccine reactogenicity and enhancing immunosafety of novel vaccines. In that context, BioVacSafe partners have a unique opportunity to tackle the urgent need to establish new ways of collaboration among industry, academia, biotech companies, regulators and patients' organizations to promote and support R&D for safer vaccines.

Also known as: BioVacSafe Project